Your browser doesn't support javascript.
loading
Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.
Loomans-Kropp, Holli A; Chaloux, Matthew; Richmond, Ellen; Umar, Asad.
Afiliación
  • Loomans-Kropp HA; Cancer Prevention Fellowship Program, Division of Cancer Prevention, NCI, Bethesda, Maryland. holli.loomans@nih.gov.
  • Chaloux M; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, NCI, Bethesda, Maryland.
  • Richmond E; Information Management Services, Rockville, Maryland.
  • Umar A; Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, NCI, Bethesda, Maryland.
Cancer Prev Res (Phila) ; 14(2): 195-204, 2021 02.
Article en En | MEDLINE | ID: mdl-32998939
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Cancer Prev Res (Phila) Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Cancer Prev Res (Phila) Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article